Route de la Corniche 5 Startlab (Alanine Building) Epalinges, 1066 SwitzerlandAt Adaptyv, we experimentally validate your protein designs to help you build better AI models and therapeutics. Our high-throughput automated wet lab in Switzerland handles DNA assembly, protein expression, and functional characterization for computational protein designers. In 2025 alone, we characterized over 40,000 proteins, serving biopharma, biotech, AI labs, and academic institutions worldwide. 𝗙𝗿𝗼𝗺 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗲 𝘂𝗽𝗹𝗼𝗮𝗱 𝘁𝗼 𝗿𝗲𝘀𝘂𝗹𝘁𝘀 𝗶𝗻 𝟯 𝘄𝗲𝗲𝗸𝘀: Upload a file with your amino acid sequences to our online portal, select your assay, and we take it from there. Results are back within 3 weeks. Our lab processes all data and delivers interactive reports with visualizations and full raw data downloadable from our portal. Throughout the experiment, you'll receive automatic status updates - from materials arriving in the lab to individual assays completing. 𝗪𝗵𝗮𝘁 𝘄𝗲 𝗰𝗵𝗮𝗿𝗮𝗰𝘁𝗲𝗿𝗶𝘇𝗲: We support de novo proteins, nanobodies (VHH), scFv, Fab, IgG, minibinders, and enzymes across binding (BLI, SPR), thermostability (nanoDSF), developability (HPLC-SEC, HIC), and enzyme activity assays. We offer cell-free expression in E. coli and yeast, as well as mammalian expression in CHO cells. Transparent and competitive per-protein pricing available at 𝗮𝗱𝗮𝗽𝘁𝘆𝘃𝗯𝗶𝗼.𝗰𝗼𝗺/𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀.

5a Route de la Corniche Alanine Building Epalinges, Vaud, 1066 SwitzerlandAt Adaptyv, we experimentally validate your protein designs to help you build better AI models and therapeutics. Our high-throughput automated wet lab in Switzerland handles DNA assembly, protein expression, and functional characterization for computational protein designers. In 2025 alone, we characterized over 40,000 proteins, serving biopharma, biotech, AI labs, and academic institutions worldwide. 𝗙𝗿𝗼𝗺 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗲 𝘂𝗽𝗹𝗼𝗮𝗱 𝘁𝗼 𝗿𝗲𝘀𝘂𝗹𝘁𝘀 𝗶𝗻 𝟯 𝘄𝗲𝗲𝗸𝘀: Upload a file with your amino acid sequences to our online portal, select your assay, and we take it from there. Results are back within 3 weeks. Our lab processes all data and delivers interactive reports with visualizations and full raw data downloadable from our portal. Throughout the experiment, you'll receive automatic status updates - from materials arriving in the lab to individual assays completing. 𝗪𝗵𝗮𝘁 𝘄𝗲 𝗰𝗵𝗮𝗿𝗮𝗰𝘁𝗲𝗿𝗶𝘇𝗲: We support de novo proteins, nanobodies (VHH), scFv, Fab, IgG, minibinders, and enzymes across binding (BLI, SPR), thermostability (nanoDSF), developability (HPLC-SEC, HIC), and enzyme activity assays. We offer cell-free expression in E. coli and yeast, as well as mammalian expression in CHO cells. Transparent and competitive per-protein pricing available at 𝗮𝗱𝗮𝗽𝘁𝘆𝘃𝗯𝗶𝗼.𝗰𝗼𝗺/𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀.

12 Chemin des Aulx Plan-les-Ouates, GE, 1228 SwitzerlandAddex Therapeutics is pioneering discovery and development of an emerging class of oral small molecule drugs, called allosteric modulators, which can be exquisitely selective for their intended target and confer significant therapeutic advantages over conventional “orthosteric” small molecule or biological drugs.

628 Rue Charles de Gaulle Crolles, Auvergne-Rhône-Alpes, 38920 FranceLe laboratoire BALAZS fait parti du groupe Air Liquide. Nous analysons les produits chimiques, l'eau ultra pure ainsi que les gaz.

Route de la Corniche 8, level -2 Epalinges , VD, 1066 SwitzerlandScreening-scale RNA-seq for hit triage, MoA profiling, toxicology, and AI training. At the throughput that early-discovery demands.

Chemin des Moines 3b Cossonay, Not Applicable, 1304 SwitzerlandScreening-scale RNA-seq for hit triage, MoA profiling, toxicology, and AI training. At the throughput that early-discovery demands.

Route de la corniche 5 Epalinges, VD, 1066 SwitzerlandScreening-scale RNA-seq for hit triage, MoA profiling, toxicology, and AI training. At the throughput that early-discovery demands.

Bachem SA Succursale de Vionnaz Route du Simplon 22 1895 Vionnaz SwitzerlandBachem offers custom peptide synthesis and GMP peptide manufacturing services, including process development, scale-up production, analytical and process validation and stability studies.

3 Route de la Corniche Biopôle - Phenyl building - 2nd floor Epalinges, Vaud, 1066 SwitzerlandAnaBioTec provides analytical insight during CMC activities for your product development & filing. With more than 20 years of experience in analytical method development and validation we help you mitigating risk and accelerating timelines. Our experienced scientific project managers connect the dots in your projects and anticipate where needed and safeguard your milestones. AnaBioTec has extensive experience with DS, complex formulations/mixtures, liposomal products, low solubility products, microspheres & derivatised products. - Small molecules - mAbs - Derivatives - Plasmids - Vaccines - mRNAs - Stem cells - CAR-T cells - PBMCs - Oligonucleotides - Peptides

EPFL Innovation Park Building A, Route Cantonale Lausanne, Vaud, CH-1015 SwitzerlandWe provide high-resolution structures using NMR crystallography

EPFL Innovation Park, Building A, Route Cantonale Laussane, Vaud, 1015 SwitzerlandWe provide high-resolution structures using NMR crystallography

13 Chemin de la Raye Ecublens, Vaud, 1024 SwitzerlandWe provide high-resolution structures using NMR crystallography

EPFL Innovation Park Building A Lausanne, Vaud, CH-1015 SwitzerlandWe provide high-resolution structures using NMR crystallography

Chemin des Aulx, 14 1228 Plan-les-Ouates, Geneva (Switzerland)ArisGen is a research-based team dedicated to innovation in the field of drug delivery as a way to improve health.

12 Avenue des Morgines CH-1213 Petit-Lancy Geneva, SwitzerlandBattelle is a GLP-compliant, IND and BLA-enabling CRO. We provide services that can help move projects from in vitro to in vivo through clinical support. Specifically, our core capabilities are focused around our long-standing experience and expertise in cell-based and biochemical assay development, validation and analytical and bioanalytical sample screening, proteomics, compound synthesis, HTP next generation sequencing, in vivo efficacy, safety pharmacology, toxicology, inhalation toxicology (small and large species), ADME/PK, analytical chemistry, pathology. Battelle also has deep experience developing and manufacturing medical devices, and in conjunction with customer test articles is able to validate both the device and test article together.

EPFL – Quartier de l'Innovation Bâtiment G 1015 Lausanne SwitzerlandBiocartis provides molecular diagnostic and multiplex detection platforms.

CH-1006 Lusanne, 0 SwitzerlandJPA Health is a woman-owned medical communications and learning solutions company. We create impactful, value-based, and customer-centric engagements that support the drug development and commercialization process from bench, to clinic, to HCP, to patient/caregiver.

c/o Gotham Labs Avenue d'Ouchy 4 Lausanne, VD, 1006 SwitzerlandBiopsomic develops proprietary liquid biopsy tests

Rue de l'Ile au Bois Monthey, 1870 SwitzerlandBiomanufacturing equipment and consumables manufacturer and distributor.

227 Route de la Chapelle 227 Route de la Chapelle Saint-Félix, Auvergne-Rhône-Alpes, 74540 FranceBioxtal is a biotech company providing services to Pharmaceutical and biotechnology companies as well as academic research labs. Bioxtal offers molecular biology and purification services (E. coli, baculovirus/insect cells, mammalian). We produce batches of recombinant proteins (with or without fusion tags, labelled protein for NMR, crystallography or imaging) for HTS or other applications. Biochemistry and biophysical services include: domain boundaries and solubility screening (Split GFP systems), activity assays development, protein interactions characterization (Protein/protein, Protein/ligand, Lead compounds screening) by TR-FRET, Isothermal Titration Calorimetry, Microscale thermophoresis, Biolayer Interferometry or Thermal shift assay. We also offer protein structure determination by X-ray crystallography (protein, protein complexes, protein/antibody complexes; protein ligand complexes; structure based drug design).

227, Route de la Chapelle 74540 SAINT FELIX - FranceWith 15 years' experience in the field of structural biology, our team confidently tackles the new challenges brought by our customers. Our scientists' dedication and creativity are our trademark. This allows Bioxtal to deliver more than the expected results whatever the challenges may be. Our determination allows us to offer a "no result- no fee" delivery i.e. we only charge if work is 100% completed.

Chemin de Montremoen 93 Crissier, 1023 SwitzerlandCalico Biosystems tests drugs directly in native patient tumors to accurately predict drug efficacy in patients. Our integrated experimental and digital approach de-risk clinical testing and reduces drug development costs by 43%

Route de la Corniche Epalinges, Vaud, 1066 SwitzerlandCalico Biosystems tests drugs directly in native patient tumors to accurately predict drug efficacy in patients. Our integrated experimental and digital approach de-risk clinical testing and reduces drug development costs by 43%

218, avenue Marie Curie Archamps Technopole Archamps, 74160 FranceCapEval Pharma provides pharmaceutical consultancy services from early pre-clinical to clinical development, specifically in the sectors of Safety, Toxicology, Pharmacology, Ophthalmology, ADME/PK, analytical development, QA, CMC-Regulatory Affairs and Compliance. In addition, CapEval provides expert assessment for due diligence, veterinary drugs, cosmetics, agrochemicals and chemicals as well as staff training.

avenue Gratta-Paille 2 1018 Lausanne, SwitzerlandCaris Life Sciences offers molecular profiling (WES/WTS), clinical trial enrollment, and IVD/CDx development services.

Impasse des Sources Ruffieux, Auvergne-Rhône-Alpes, 73310 FranceCellMade is a biopharmaceutical company focused on the development and commercialization of early diagnostic and prognostic tests and novel therapeutics to prevent development of Metabolic Disease and related co-morbidities. The ever-increasing prevalence of Obesity affects millions of people worldwide. The Metabolic Syndrome and its hepatic manifestation, NAFLD-NASH is a key pathological condition triggered by the noxious biochemical pathways of Obesity. Despite the high unmet medical needs, there are currently no approved drugs for treating NAFLD-NASH. The current main recommendation is lifestyle modification, which is only partially effective. The scientific evidence on the looming pandemic of Obesity is now overwhelming. It is thought that the spreading of the disease is mediated via circulating inflammatory messengers. As in any degenerative disease, early diagnosis is the key to avoid harmful, and even deadly, effects. There is high demand for a non-invasive, high-accuracy diagnostic and prognostic approach. CellMade identified and validated a set of blood lipids that allow for discrimination between the various stages of NAFLD-NASH enabling to predict patient's risk profile and reactivity to treatment schedules. The successful validation of the biomarker signatures represents a cornerstone advancement to address the societal challenges related to the Obesity pandemic and the development of associated comorbidities such as T2DM, CVD and COPD. Early diagnosis will overcome the costs issues affecting the current clinical scenario, as the disease development is still reversible and could be addressed therapeutically. We at CellMade believe in Open Innovation and therefore established a dedicated range of laboratory services, derived from our own research activities, that can help scientists in further developing tools for Metabolic Disease. Our multidisciplinary team has developed an innovative systems biology approach enabling high-content and robust analysis of cell models required for a diverse range of applications such as efficacy and safety testing of new drug compounds or the discovery of biomarkers. CellMade provides a comprehensive catalog of Services: Biobanking, Cell-based assays, Cytometry and Mass Spectrometry assays and Bioinformatics for annotation of obtained data and construction of data-bases.

10 Avenue de la Gare Lausanne, Vaud, CH-1003 SwitzerlandChemAlive SA serves an online computational chemistry platform that delivers highly accurate analytics for all of chemistry through its managed cloud computing, its in-house automation algorithms and its large-scale database. Through one-button, barrierless, access to state-of-the-art methods in chemical theory, the platform allows for fast and efficient results with up-to-date methodologies useful to experts and non-experts alike in academia, pharmaceuticals, fine chemicals and contract research (manufacturing) organizations (CR(M)Os). The ultimate goal of ChemAlive SA is to allow the full and automatic calculation of reliable quantum data for molecular properties and synthetic reactions available to all chemists from basic 2D chemical syntax towards the total in silico prediction of chemical processes.

38043 Grenoble CEDEX 9 Grenoble FranceThe University hospital Grenoble Alpes (CHU of Grenoble ) is a French university hospital center.

Chemin Messidor 5, 1006 Lausanne, Lausanne, Vaud, SwitzerlandDebiopharm Group specializes on the development of innovative therapies and prescription drugs that target unmet medical needs.

EPFL Innovation Park Batiment D Lausanne, CH-1015 SwitzerlandDOPPL - Disrupting healthcare with our high resolution, automated organoid factory Exploiting the power of bioengineered technologies, DOPPL is the leading platform for high-throughput organoid culture and screenings for many tissue types and multiple phenotypic readouts. The DOPPL platform features a large cohort of organoid models and their associated data in a biobank, automated workflows for unlimited organoid expansion and use in large scale screens, and imaging capabilities. DOPPL engages in partnered projects for novel in vitro model generation and screening in drug development. Applications include patient-specific targeted therapy screening in cancer organoids, novel T-cell killing assay methodologies for immuno-oncology studies, toxicity assessment and transport studies on gastrointestinal organoids, and on organoid-based blood-brain barrier model.

EPFL Innovation Park Building D Lausanne, VD, 1015 SwitzerlandDOPPL - Disrupting healthcare with our high resolution, automated organoid factory Exploiting the power of bioengineered technologies, DOPPL is the leading platform for high-throughput organoid culture and screenings for many tissue types and multiple phenotypic readouts. The DOPPL platform features a large cohort of organoid models and their associated data in a biobank, automated workflows for unlimited organoid expansion and use in large scale screens, and imaging capabilities. DOPPL engages in partnered projects for novel in vitro model generation and screening in drug development. Applications include patient-specific targeted therapy screening in cancer organoids, novel T-cell killing assay methodologies for immuno-oncology studies, toxicity assessment and transport studies on gastrointestinal organoids, and on organoid-based blood-brain barrier model.

Chemin des Aulx, 16 Plan-les-Ouates, Geneva, 1228 Switzerland

CE 3 316 (Centre Est), Station 1 Lausanne, CH-1015 SwitzerlandEcoles Polytech. fédérales de Lausanne provides chemistry, research, and technology transfer.

Av. Etienne Guillemin 16 P.O. Box 64 CH-1009 Pully SwitzerlandECOM Agroindustrial Corp. Ltd is a leading global commodity merchant and sustainable supply chain management company. As an origin-integrated business operating in over 40 major producing countries worldwide, ECOM focuses primarily on coffee, cotton, and cocoa, as well as participating in selected other agricultural product markets.

EPFL SV ISREC Station 19 Lausanne, CH-1015 SwitzerlandISREC is integrated into the School of Life Sciences at EPFL, where it shares a new building (Bâtiment SV) with the Global Health Institute. Its faculty continues to investigate a spectrum of fundamental biological systems that are variously co-opted or disrupted during the development of cancer. Prominent amongst the research topics are signalling pathways that normally regulate aspects of embryogenesis and organogenesis, and mechanisms orchestrating the cell division cycle and the maintenance of genomic integrity during cell proliferation. Increasingly, genetically engineered mouse models of human cancer are being employed to elucidate the roles of such signalling circuits and regulatory mechanisms in tumors, as well as the complex interplay of cancer cells with ostensibly normal cells in their collective "tumor microenvironment"; such heterotypic cell-cell interactions are proving instrumental for malignant progression of tumors to lethal disease. The new director - Douglas Hanahan, from the University of California at San Francisco - is developing a novel strategic plan for ISREC, involving increasing focus via new faculty recruitments on directly studying mechanisms of cancer in model systems and in human tumors, notably involving outreach to the medical oncology community in the region. Toward that end ISREC will establish a bridge-building 'translational' oncology branch at the University of Lausanne's medical campus (CHUV) intended to foster by its proximity and emphasis catalytic interactions and cooperative research with clinical cancer researchers. Both branches of ISREC will seek to expedite progress toward deeper understanding of the biology and genetics of cancer, in turn leveraging new knowledge forthcoming to develop and test innovative drug targeting strategies aimed to disrupt critical mechanisms of the disease and thereby improve the benefits of cancer therapy. The independent ISREC Foundation (http://www.isrec.ch) is focussed on supporting innovative cancer research in Lausanne and western Switzerland, in particular at the frontier of translational oncology that has promise to positively impact the future treatment of human cancer.

18 chemin des Aulx CH-1228 Plan-Les-Ouates Genève SwitzerlandEpithelix provides in vitro human tissues, high throughput screening, and chemical testing. Epithelix Sàrl provides alternative in vitro solutions to animal experimentation for evaluating the effects of drugs in development and assess the toxicity of chemical compounds on the human respiratory tract. The company is the European leading provider of in vitro reconstituted human respiratory tissues and related services to leading academic research laboratories. Epithelix also supplies and supports Personal Care, Medical Device, as well as Chemical and Pharmaceutical. Epithelix developed a unique technology allowing reconstituted tissues to be maintained at a homeostatic state for a long period of time; in other words, the tissues resemble the native tissue both morphologically and functionally (see our products page). The company focused initially on the respiratory system and marketed MucilAir™, the only human respiratory epithelium model able to remain fully differentiated and functional for more than one year. This model is commercialized and available in US, Europe and Asia.

18 chemin des Aulx Plan-les-Ouates, Genève, 1228 SwitzerlandEpithelix provides in vitro human tissues, high throughput screening, and chemical testing. Epithelix Sàrl provides alternative in vitro solutions to animal experimentation for evaluating the effects of drugs in development and assess the toxicity of chemical compounds on the human respiratory tract. The company is the European leading provider of in vitro reconstituted human respiratory tissues and related services to leading academic research laboratories. Epithelix also supplies and supports Personal Care, Medical Device, as well as Chemical and Pharmaceutical. Epithelix developed a unique technology allowing reconstituted tissues to be maintained at a homeostatic state for a long period of time; in other words, the tissues resemble the native tissue both morphologically and functionally (see our products page). The company focused initially on the respiratory system and marketed MucilAir™, the only human respiratory epithelium model able to remain fully differentiated and functional for more than one year. This model is commercialized and available in US, Europe and Asia.

18 chemin des Aulx Plan-les-Ouate Plan les Ouates, Geneva, 1228 SwitzerlandEpithelix provides in vitro human tissues, high throughput screening, and chemical testing. Epithelix Sàrl provides alternative in vitro solutions to animal experimentation for evaluating the effects of drugs in development and assess the toxicity of chemical compounds on the human respiratory tract. The company is the European leading provider of in vitro reconstituted human respiratory tissues and related services to leading academic research laboratories. Epithelix also supplies and supports Personal Care, Medical Device, as well as Chemical and Pharmaceutical. Epithelix developed a unique technology allowing reconstituted tissues to be maintained at a homeostatic state for a long period of time; in other words, the tissues resemble the native tissue both morphologically and functionally (see our products page). The company focused initially on the respiratory system and marketed MucilAir™, the only human respiratory epithelium model able to remain fully differentiated and functional for more than one year. This model is commercialized and available in US, Europe and Asia.

ZA du Borrey -F-01100 MARTIGNAT FranceErcé plasturgie specializes in liquid dosing systems and primary packaging.

Route de l'ile-au-bois 1A CH-1870 Monthey, Valais SwitzerlandWith more than 300 completed cell line development projects and over 50 ExcellGene cell lines already in the clinic, ExcellGene is a trusted partner for high‑performance biologics development. Our proprietary CHO and HEK293 systems deliver exceptional productivity and consistency, enabling rapid progress for bispecifics, multi specifics, antibodies, and other demanding modalities. We provide flexible, end‑to‑end solutions spanning early discovery through clinical development to help teams reach milestones with confidence.

Rue du Champ-Blanchod 4 Plan-les-Ouates, Geneva, 1228 SwitzerlandFasteris is the Life Science brand of Genesupport, a Swiss laboratory which serves, not only genetic diagnostic services, but also Next Generation Sequencing (NGS) and Sanger sequencing services for LifeScience reseach worldwide, such as private, academic, governmental and industrial research laboratories, as well as to biotechnology and pharma companies. Genesupport is part of Medisupport, the Swiss laboratory networks, a strategical partnership that allows us to offer a large panel of medical and diagnostic analyses. Medisupport belongs to the SONIC Healthcare network, a global healthcare company with reputation for excellence in laboratory medicine and pathology, radiology and diagnostic imaging, as well as primary care medical services.

Geneva, SwitzerlandFirmenich is in the perfume and flavor business and also provides organic synthesis and biotechnology services.

c/o Science Innovation Hub Quai Ernest-Ansermet 30 Geneva, Geneva, 1205 SwitzerlandFluoSphera has developed a cutting-edge technology platform to discover new drugs with human multi-tissue systems faithfully mimicking clinical drug responses. This enables high-resolution drug profiling before clinical trials, with strong human and systemic relevance.

29, Quai du Mont-Blanc-PO Box 133 Geneva 21, CH-1211 SwitzerlandGenexion offers development of biopharmaceutical products specifically targeting chronic inflammatory and autoimmune disease.

5, Chemin de la Parfumerie Vernier, 1214 SwitzerlandAs the world’s leading flavour and fragrances company, we unveil the tastes and scents that suit you best, and that you love most.

5a Route de la Corniche Epalinges, Vaud, 1066 SwitzerlandHedera Dx is a precision oncology company delivering integrated liquid and tissue biopsy solutions that enable faster, more accessible genomic testing directly within hospital systems. Beyond diagnostics, the company is rapidly expanding a global network of clinico-genomic, longitudinal research programmes that generate high-quality real-world evidence across EMEA, Canada, and APAC. By embedding data capture into routine care, Hedera Dx links genomic insights with clinical outcomes at scale—supporting biomarker discovery, optimizing treatment decisions, and accelerating drug development for partners worldwide.

Avenue Des Uttins 3 1180 Rolle SwitzerlandBacked by decades of experience in developing and licensing industrial-scale technology, INEOS Bio creates more sustainable communities and transportation by converting waste and non-food crop biomass into advanced biofuel. The INEOS Bio bioenergy technology solution uses a flexible approach that is safe, fast and reliable, allowing it to be commercialized wherever there is waste. By taking this localized approach, INEOS Bio reduces landfill and air pollution, creates jobs, generates tax revenue and safely produces renewable fuel and clean energy.

Rte. de l’Ile-au-Bois 1A Monthey/VS, 1870 SwitzerlandIHMA is a global leading central reference laboratory, dedicated to supporting infectious disease innovation. We partner with pharmaceutical, biotechnology, and diagnostic companies developing antimicrobial therapies and testing—including antibiotics, bacteriophage treatments, and vaccines with extensive molecular support. Our AMR surveillance programs and testing capabilities span across the globe include India & China. IHMA delivers comprehensive bacteriology and clinical microbiology services.

64 Rue de Lausanne Renens, Vaud, 1020 SwitzerlandIsospec overcomes long-standing bottlenecks in metabolomics and glycoproteomics by unlocking molecular layers closely linked to healthcare applications. Our platform integrates CIRIS with multi-layered data analytics and AI-based interpretation to generate large-scale, structure-resolved datasets from patient samples, providing actionable insights. By providing high-throughput, robust analytical tools, Isospec supports faster, de-risked, and cost-efficient drug development while delivering structure-based omics capabilities accessible to biomedical research worldwide.

5 Avenue Napoléon III 5 Av. Napoléon III Saint-Julien-en-Genevois, Auvergne-Rhône-Alpes, 74160 FranceJubilant Biosys Limited has over 20 years of experience in delivering Integrated Drug Discovery (IDD) and GMP development and manufacturing. Serving the global pharma industry, Jubilant Biosys employs over 2,400 people operating from five sites in India, with a presence in the USA, Europe, and Japan. The company is recognized in the industry for its scientific innovation, problem-solving mindset, and unwavering attention to customers' needs. Jubilant Biosys has evolved as a leading CRDMO (Contract Research, Development, and Manufacturing Organization) partner in science, offering a full spectrum of services in drug discovery, development, and manufacturing. With the addition of biologics such as ADCs (Antibody-Drug Conjugates), mAbs (Monoclonal Antibodies) and large molecules like oligonucleotides, and peptides, the company has grown into an integrated entity, delivering end-to-end solutions from early discovery phases—including biology, medicinal chemistry, DMPK (Drug Metabolism and Pharmacokinetics), and toxicology—to chemical development and manufacturing of GMP (Good Manufacturing Practice) intermediates and APIs (Active Pharmaceutical Ingredients) for both clinical and commercial supplies. Biosys has consolidated advances in drug discovery by utilizing the latest AI/ML technologies and by incorporation of environment-friendly processes. This enables Biosys to partner with leading companies on the most challenging, cost and time-sensitive drug discovery and development programs. With a strong commitment to new technologies, supply chain, Quality, and ESG considerations, Biosys is a leading CRDMO partner for Big Pharma companies and Biotech.

EPFL Innovation Park, building A Lausanne, VAUD, 1015 SwitzerlandLunaphore is a Swiss firm born with the vision of bringing spatial biology mainstream. Lunaphore develops innovative tissue staining platforms based on a cutting-edge technology, providing high quality results much faster than current techniques and aiming to automate some of the most sophisticated assays thanks to high-precision fluidics. We further enable digital pathology through the integration of imaging systems such as a microscope with sequential data extraction. Lunaphore has been repeatedly recognized for its innovation.

Route de Lully 5C Tolochenaz, Vaud, 1131 SwitzerlandLunaphore is a Swiss firm born with the vision of bringing spatial biology mainstream. Lunaphore develops innovative tissue staining platforms based on a cutting-edge technology, providing high quality results much faster than current techniques and aiming to automate some of the most sophisticated assays thanks to high-precision fluidics. We further enable digital pathology through the integration of imaging systems such as a microscope with sequential data extraction. Lunaphore has been repeatedly recognized for its innovation.

Lausanne, VD SwitzerlandLyncée Tec is making the invisible visible enabling you to characterize your samples like you couldn’t before!

Route de Pré-Bois 29 P.O. Box 527 1215 Genève 15 SwitzerlandMed Discovery provides clinical development for the treatment of cancer including uro-genital and oncology fields.

31, avenue Arsène d’Arsonval F-01000 Bourg en Bresse, FranceMedelpharm provides tableting equipment, software, formulation, powder analysis and characterization.

PO Box 1826 20, rte de Pré-Bois 1215 Geneva 15, SwitzerlandMMV, a not-for-profit public-private partnership, was established as a foundation in Switzerland in 1999. Our mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and delivering new, effective and affordable antimalarial drugs. Our vision is a world in which these innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and help to ultimately eradicate this terrible disease.

Chemin des Aulx 14 Plan-les-Ouates Geneva, Geneva, 1228 SwitzerlandMesenFlow delivers human tissue–based platforms that model inflammation under physiological flow. We provide faster, cost-efficient and animal-free preclinical insights into compound safety, efficacy and mechanism of action. We help pharma and biotech increase predictive accuracy and reduce development risk across inflammation, oncology and toxicology.

Eclosion Foundation Chemin des Aulx, 14 Geneva, Geneva, CH1228 SwitzerlandMesenFlow delivers human tissue–based platforms that model inflammation under physiological flow. We provide faster, cost-efficient and animal-free preclinical insights into compound safety, efficacy and mechanism of action. We help pharma and biotech increase predictive accuracy and reduce development risk across inflammation, oncology and toxicology.

Didier Blanchard 219 Chemin des Demays Saint Joseph de Rivière, 38134 FranceWe provide a new mode for accessing synchrotron facilities for high-throughput, high-resolution & high-energy X-ray measurements and advanced data analytics. Our measurements include high-resolution X-ray powder diffraction, total scattering pair distribution function analysis, and small-angle scattering. Our services are suitable for characterization of crystalline, nano-structured and amorphous materials, and we can help at all stages of product development including materials discovery, structure determination, structure-property relationship determination, process optimization, quality control.

4 Route de la Corniche, Epalinges, VD 1066, CHMYMETICS: THE POWER OF A UNIQUE TECHNOLOGY TO DEVELOP NEXT-GENERATION PROPHYLACTIC VACCINES FOR INFECTIOUS DISEASES Our vaccines are designed to induce protection against early transmission and infection, focusing both on the mucosal immune response as a first-line defense and the systemic humoral (blood) immune response, which, for some pathogens, may be essential for the development of an effective prophylactic vaccine. Our unique approach has resulted in the development of a rich pipeline of 5 vaccine candidates for HIV-1/AIDS, intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncytial Virus (RSV) vaccine. Our delivery platform is being validated through partnership with leading pharmaceutical or research organisations, including Astellas Pharma, PATH-MVI and the Bill and Melinda Gates Foundation. Mymetics Corporation (OTCQB: MYMX) is a Swiss based biotechnology company, with a Research Lab in the Netherlands. The company is registered in the US and trades on the OTCQB.

EPFL Innovation Park (M) Rue des Jordils 1A 1025 Saint-Sulpice, 1025 SwitzerlandKey service areas for SydLab (TM) One, our proprietary, high throughput C. elegans-on-chip platform include: aging, healthspan and lifespan general toxicology, neurodegeneration, developmental and reproductive toxicology, chemical testing for the foods/flavors and chemicals industries, probiotic and microbiome testing. Key readouts include but are not limited to live video, imaging (brightfield and fluorescence) worm count, worm motility, length, area & volume, egg emergence and counts, progeny and larvae metrics. Combine these automated readouts with offline bioassays for metabolism, mRNA and high resolution confocal imaging, and your data sets become even richer and provide more detail insights for accurate decision making. All work is carried out in our lab in Saint Sulpice, Switzerland. At Nagi Bioscience, we create cutting-edge solutions that unlock the power of innovative biological models and deliver the insights scientists need to accelerate life-changing discoveries. The company is supported by 10+ years of research behind the technology and science, with over 50 years’ industry experience across our multidisciplinary team. Nagi Bioscience technology is supporting 30+ publications and multiple successful projects executed with industry recognized experts and partners. We are well positioned to be a viable solution for your C. elegans research goals. We do not offer vertebrate/mammalian models for any of the service areas listed above.

EPFL Innovation Park Chemin de la Dent d’Oche 1A 1024 Ecublens SwitzerlandWe are scientists, working for scientists. Our belief is that each and every Biologist, Researcher and Physician should be able to explore and interact instantly with living cells without damaging them. We want to support the study of how living cells and bacteria work, evolve and react, thus building a solid base for new drugs and therapies, in order to enable breakthrough researches. This is the reason why we have developed the 3D Cell Explorer. Nanolive SA was incorporated in November 2013 at the EPFL Innovation Park in Lausanne, Switzerland, by Dr. Yann Cotte (CEO) and Dr. Fatih Toy (scientific advisor), following the completion of their respective PhD theses at the EPFL Microsystems laboratory of Prof. Christian Depeursinge (Head of Scientific Advisory Board). Late 2013, Dr. Andreas Kern and Dr. Sebastien Equis joined as Co-Founders to lead the software development and hardware construction respectively. Now the team is composed by eleven people from very different backgrounds and geographical origins: engineers, biologists, physicists and business. Dr. Lisa Pollaro was hired Spring 2014 as Communication Manager, Dr. Sorin Pop as Software Engineer for Image Processing and Nicolas Pignier as Mechanical Engineer. In 2015 the team expanded with Dr. Bastien Dalla Piazza who joined as head of scientific software, Álvaro Hernández Prieto, as head of embedded software and electronics, Sabine Bautz as operation specialist and Martina Biserni as R&D biologist.

Route Cantonale Lausanne, VD, 1015 SwitzerlandWe are scientists, working for scientists. Our belief is that each and every Biologist, Researcher and Physician should be able to explore and interact instantly with living cells without damaging them. We want to support the study of how living cells and bacteria work, evolve and react, thus building a solid base for new drugs and therapies, in order to enable breakthrough researches. This is the reason why we have developed the 3D Cell Explorer. Nanolive SA was incorporated in November 2013 at the EPFL Innovation Park in Lausanne, Switzerland, by Dr. Yann Cotte (CEO) and Dr. Fatih Toy (scientific advisor), following the completion of their respective PhD theses at the EPFL Microsystems laboratory of Prof. Christian Depeursinge (Head of Scientific Advisory Board). Late 2013, Dr. Andreas Kern and Dr. Sebastien Equis joined as Co-Founders to lead the software development and hardware construction respectively. Now the team is composed by eleven people from very different backgrounds and geographical origins: engineers, biologists, physicists and business. Dr. Lisa Pollaro was hired Spring 2014 as Communication Manager, Dr. Sorin Pop as Software Engineer for Image Processing and Nicolas Pignier as Mechanical Engineer. In 2015 the team expanded with Dr. Bastien Dalla Piazza who joined as head of scientific software, Álvaro Hernández Prieto, as head of embedded software and electronics, Sabine Bautz as operation specialist and Martina Biserni as R&D biologist.

Sciences III - University of GenevaNCCR Frontiers in Genetics offers genomics and bioimaging services.

64, Avenue de la Roseraie Geneva, Geneva, 1205 SwitzerlandNEURIX: 3D Human Neural Models for Drug Discovery and Neuroscience Research NEURIX drives preclinical research with its 3D in vitro human brain models, delivering unparalleled insights into drug discovery, disease modelling and toxicity screening. Our advanced platforms, derived from human iPSC technology, include models for Glioblastoma, Blood-Brain Barrier (BBB), Parkinson’s, and Alzheimer’s Disease, providing physiologically relevant systems to accelerate scientific breakthroughs. 🔬 Our services are designed to support your research with: • Drug Testing & Toxicity Screening – Predictive and human-relevant models for preclinical compound evaluation, including assessment of cancer and cell & gene therapy strategies. • Neurodegenerative Disease Modelling – High-fidelity models of Alzheimer’s and Parkinson’s Disease for therapeutic development. • Custom 3D Neural Cultures – Scalable, reproducible brain-like tissues tailored to your study needs. With over a decade of expertise and backed by European research grants, NEURIX is your trusted partner in neuroscience. Our validated, scalable platforms provide highly predictive translational models, helping to de-risk drug development and improve clinical application. Contact us today to integrate NEURIX’s human 3D brain models into your research and accelerate validation of your therapeutic innovations to reach patients faster.

EPFL Innovation Park building B Lausanne, Lausanne, 1015 SwitzerlandNIMGenetics provides advanced Genomics, Transcriptomics, Bioinformatics and cell line characterization services leveraging NGS, Single-cell and arrayCGH technologies and expertise to support Biopharma Industry, CROs and Academic Researchers. With the recent purchase of Gene Predictis SA in Switzerland, we also include molecular microbiology analyses, polygenic risk scores development, genotyping platform & possibility to design custom genotyping arrays and validated based on our DNAtek, in vitro diagnostics development and pharmacogenetics At NIMGenetics, we pride ourselves on the Speed, Competitive Pricing and Tailored R&D Services we can offer our partners. Furthermore, NIMGenetics becomes the first human genetic diagnosis company in the world to be certified as a B Corp, thus accrediting its generation of positive social and environmental impact through its activity. We integrate the most modern technologies with an internally developed pipeline for genomic analysis, applying our own bioinformatics tools, Artificial Intelligence (AI), Machine Learning (ML) and a large proprietary genetic database. In addition, NIMGenetics’ Clinical Relationships, in Leading Hospitals and Clinics, as well as our Repository of Clinical Genomics Data, makes us an especially interesting partner to support R&D projects from the Earliest Discovery and Preclinical Stages to Clinical Trials and Companion Diagnostics (CDx). NIMGenetics offers Research and Development Support Services such as: Whole-Genome and Exome Sequencing, Gene Expression (RNASeq, Single Cell and Methylation Profiling), DNA-Encoded Chemical Libraries, Genomics for Cell and Gene Therapy, Optical Genome Mapping, CRISPR Off-target Effects, Viral Vector Integration Analysis, Bioinformatics Analysis, a growing Genomics Database of under-represented populations from the Iberian Peninsula and Latin America, and tailor-made R&D Consultancy projects. We support researchers in Oncology, Rare Diseases, Regenerative Medicine, Neurodevelopmental and Neurodegenerative Diseases, Gynecology and Reproductive Medicine, GastrointestinaI, Microbiome and a wealth of other Research Areas.

3 Route de la Corniche Biopole - Building Phenyl Epalinges, Vaud, 1066 SwitzerlandNovigenix AI is a pioneering TechBio delivering liquid biopsy multi-omic solutions powered by the LITOSeek™ AI-RNA analytics platform to accelerate early cancer detection and development of effective therapies for better patient outcomes.

Route de la corniches Epalinges, 1066 SwitzerlandOHMX.bio is a speciality lab focussed on providing sequencing solutions. Our mission is to catalyze your scientific breakthroughs with unparalleled quality and insights. As a partner for companies in discovery and (pre)clinical phases, we promise success through guaranteed results and a commitment to excellence. We offer multi-omics solutions in the field of (epi)genomics, translatomics, transcriptomics, proteomics and bioinformatics. We have tailored pipelines with extra QC steps to make sure your samples are processed efficiently and with quality (NO garbage in, garbage out). We can process several sample types ranging from fluids and tissues to FFPE and cell pellets. All our services can be combined with custom tailored bio-informatical analyses and output. Our platforms are broad and include both short-read (Illumina, AVITI) and long-read sequencing (Nanopore). We also offer a dedicated ribo-seq pipeline and can do single-cell sequencing (PACBIO, 10XGenomics). Contact us today if you want a personal approach, want quality and OHMX.bio, a proud member of the Anacura Group, is a full-service Contract Research Organization (CRO) specializing in comprehensive multi-omics solutions. We are dedicated to supporting pharmaceutical, biotechnology, and academic institutions in their discovery and (pre)clinical research, including clinical trials. All our services are performed in-house, ensuring stringent quality control and seamless project management from sample to data. Our expertise encompasses a broad spectrum of services, including: Next-Generation Sequencing (NGS): Utilizing both short-read (Illumina, AVITI) and long-read (Oxford Nanopore Technologies) platforms for genomics, transcriptomics, and epigenomics. We offer specialized applications such as RNA sequencing (RNA-seq), ribo-sequencing (ribo-seq), and single-cell sequencing (10x Genomics, PacBio). Quantitative Polymerase Chain Reaction (qPCR): For precise and sensitive gene expression analysis and validation. Proteomics: Comprehensive protein identification, quantification, and characterization. Bioinformatics: Advanced data analysis, interpretation, and custom report generation, including statistical analysis and pathway analysis. We process a wide range of sample types, including but not limited to biofluids, tissues, FFPE, and cell pellets. Our robust, tailored pipelines incorporate extensive quality control measures to ensure data integrity and reliability. OHMX.bio is committed to delivering high-quality, reproducible results and actionable insights to accelerate your research and development programs. Partner with us for a reliable and efficient multi-omics solution.want proper scientific support. We deliver the right solution for you and will help you further progress your research.

5 Avenue Napoléon III Saint-Julien-en-Genevois, Auvergne-Rhône-Alpes, 74160 FranceGlobal leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical synthesis and biological processes while always embracing the highest international safety, quality, and environmental standards.

Avenue de Sevelin 28 Lausanne, Vaud, 1004 SwitzerlandORYL Photonics SA is a Swiss deep-tech company commercializing Ultrafast Light Scattering (ULS) — a proprietary measurement technology that combines Second Harmonic Scattering and Linear Light Scattering on a single benchtop, plate-based instrument. The ORYL F1 profiles solubility and aggregation ~100× faster and with ~100× less compound than HPLC, and is the only plate-based system that reliably handles high-concentration biologics (>50 mg/mL) and new modalities (PROTACs, macrocycles) where DLS, SLS and HPLC saturate or fail. Founded in 2020 as an EPFL spin-off and headquartered at Biopôle.

Route de la Corniche 5B, Biopole Epalinges, Vaud, 1066 SwitzerlandORYL Photonics SA is a Swiss deep-tech company commercializing Ultrafast Light Scattering (ULS) — a proprietary measurement technology that combines Second Harmonic Scattering and Linear Light Scattering on a single benchtop, plate-based instrument. The ORYL F1 profiles solubility and aggregation ~100× faster and with ~100× less compound than HPLC, and is the only plate-based system that reliably handles high-concentration biologics (>50 mg/mL) and new modalities (PROTACs, macrocycles) where DLS, SLS and HPLC saturate or fail. Founded in 2020 as an EPFL spin-off and headquartered at Biopôle.

Station 17 Lausanne, Vaud, 1004 SwitzerlandORYL Photonics SA is a Swiss deep-tech company commercializing Ultrafast Light Scattering (ULS) — a proprietary measurement technology that combines Second Harmonic Scattering and Linear Light Scattering on a single benchtop, plate-based instrument. The ORYL F1 profiles solubility and aggregation ~100× faster and with ~100× less compound than HPLC, and is the only plate-based system that reliably handles high-concentration biologics (>50 mg/mL) and new modalities (PROTACs, macrocycles) where DLS, SLS and HPLC saturate or fail. Founded in 2020 as an EPFL spin-off and headquartered at Biopôle.

Rue François Bellot Genève, Genève, 1206 SwitzerlandOwkin is an agentic AI company on a mission to explore complex biology to speed up and scale research for the creation of new treatments and diagnostics for patients. Owkin K, our AI co-pilot combines unparalleled access to multimodal data, cutting-edge AI to quantify biology and pioneering agentic AI to achieve Biological Artificial Superintelligence in the future.

Z.I du ClairayPANPHARMA offers contract manufacturing for powders for injection, liquids, and suspensions in addition to API supply/analysis services.

Route de la Corniche 4 Epalinges, CH-1066 Switzerland Preclin Biosystems AG offers a comprehensive in vivo preclinical testing platform for the identification and validation of lead candidate therapeutics. We specialize in preclinical models of chronic inflammatory and infectious diseases. We offer a fully customizable service ensuring your development goals are achieved. We provide the expertise to unravel a drugs mechanism of action, optimal route and regime of administration, and efficacy in defined disease indications.

EPFL, Innovation Park Building G Lausanne, Vaud, 1015 SwitzerlandQGel develops and commercializes biotechnology products of therapeutic relevance to improve methods for research and diagnostics in the field of life science, including 3D cell culture extracellular matrices.

avenue de Sécheron 15 Switzerland Geneva, 1202 SwitzerlandQuartz Bio is a service company specialized in the computational analysis of biomarker data from clinical trials.

Avenue de Sécheron 15, Geneva, CH-1202 SwitzerlandQuartz Bio is a service company specialized in the computational analysis of biomarker data from clinical trials.

Z.I. du Vivier 22 CH-1690 Villaz-St-Pierre SwitzerlandA new dimension to biomedical engineering regenHU is an innovative biomedical company located in Switzerland, belonging to the CPA Group SA. regenHU acts as a biosystem architect exploiting new biomanufacturing solutions in order to respond to the emerging challenges facing the biomedical industry. regenHU benefits from exclusive patented technologies resulting from many years of research within international universities and partners.

Villaz-Saint-Pierre, FR, 1690 SwitzerlandA new dimension to biomedical engineering regenHU is an innovative biomedical company located in Switzerland, belonging to the CPA Group SA. regenHU acts as a biosystem architect exploiting new biomanufacturing solutions in order to respond to the emerging challenges facing the biomedical industry. regenHU benefits from exclusive patented technologies resulting from many years of research within international universities and partners.

746, avenue Ambroise Croizat Crolles, 38920 FranceScientist.com is the world’s largest marketplace for medical research. We help pharmaceutical scientists discover life-saving medicines in less time and at lower cost. Our mission is to make it possible to cure all human disease by 2050. By connecting scientists and enabling them to exchange ideas and transact seamlessly online, Scientist.com is speeding up and reducing the cost of medical research. We were founded in 2007, launched our first research outsourcing marketplace in 2008 and built our first enterprise marketplace for Pfizer in 2009. Today, we operate enterprise marketplaces for 24 of the world’s top 30 pharmaceutical companies, 100+ biotechnology companies and the US National Institutes of Health (NIH).

StartLab, Biopole, Building SE-B Route de la Corniche 5 Epalinges, Vaud, 1066 SwitzerlandAt SEED Biosciences we make DISPENCELL, an automated laboratory instrument designed for fast, easy and gentle single cell isolation. Designed by scientists for scientists, DISPENCELL has been thought to quickly integrate your lab routine in a plug-and-play approach. Flexible and effortless, DISPENCELL operates equally under sterile conditions in a culture hood, or on a simple benchtop.

Plan-les-Ouates, GE SwitzerlandSelexis offers mammalian cell line development and cell line technology products and services.

Health Science Division, with laboratory at 14, chemin des Aulx Plan-Les-Ouates, CH-1228 SwitzerlandSGS helps pharmaceutical, biopharmaceutical, and medical device companies by providing services along the entire drug development pathway. As a global contract research organization, our global Health Science team provides integrated solutions from preclinical activities to Phase I-IV clinical trials, bioanalytical, pharmaceutical development, biologics characterization, biosafety, and quality control testing of small and large molecules, raw materials, containers and finished products. In an ever-changing world, with technological change reaching breakneck speed, SGS helps navigate the sometimes complex process to successfully deliver high quality, safe and medical devices to market. SGS boasts a wealth of global health science expertise. We will support you every step of the way as you deliver first-class, fully compliant biopharmaceutical, pharmaceutical and medical device products. Our expert staff is trained to the highest standards and has an in-depth knowledge of their fields and your business needs.

Route du Simplon 22Sochinaz offers cytotoxic API production, chiral synthesis, high pressure reactions, high potency compounds, and manufacturing services.

8, rue John Grasset CH 1205 Geneva SwitzerlandAt Solid Drug Development, we offer you a broad spectrum of drug development services, including technology transfer operations. Our expertise ranges across CMC, non-clinical, clinical, regulatory and strategic concerns and we strive to provide you with the best possible solutions.

ZA La Pièce Rolle, Vaud, 1180 SwitzerlandSOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of SOPHiA DDM™, a platform that analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.

ZA La Pièce Rolle, 1180 SwitzerlandSOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of SOPHiA DDM™, a platform that analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.

9B Route de la Corniche Epalinges, VD, 1066 SwitzerlandThe mission of TCMetrix is to provide researchers in clinical and basic sciences worldwide with innovative, state-of-the-art T cell monitoring reagents of high quality, to meet the increasing needs for conclusive and comprehensive MHC class I and class II T cell monitoring and analysis. Because blood samples are precious and the value of T cell analysis critically depends on the quality of the reagents used, TCMetrix is committed to provide only highest quality reagents. Each reagent will be delivered with quality control data demonstrating the biochemical purity and integrity of the reagent and whenever possible with T cell staining data. In addition, each shipment will contain a product data sheet providing information on the stability of the reagent, the recommended storage and CD4+ and CD8+ T cell staining conditions. While the primary focus is on the production of reagents for quantification and analysis of tumor antigen-specific T cell responses, TCMetrix endeavours to extend the scope of its services to other disorders, such as infectious diseases, autoimmunity and allergies. Because blood samples usually are small, T cell responses diverse and of low frequencies, especially tumor antigen specific ones, TCMetrix is developing parallel and sequential combinatorial staining strategies that use reversible and irreversible MHC-peptide multimers and antibodies and allow phenotypic and functional analysis on multiple CD8+ and/or CD4+ T cell specificities. A major challenge for TCMetrix is to provide reagents and services that allow integral analysis of antigen-specific T cells for a better understanding of their diverse roles in adaptive immunity, in particular in cancer-specific immune reactions. TCMetrix endorses the MIATA reporting framework and strongly encourages its adoption.

175 Route de Chancy Confignon, Genève, 1232 SwitzerlandExpertise in Data and Digital in Life Sciences

BioPark le Forum 1-2 260 avenue Marie Curie Archamps, Haute-Savoie, 74160 FranceTransCure BioServices is the only CRO specialized in preclinical studies using full human immune system (CD34 engrafted and PBMC engrafted) and humanized liver mouse models. We provide predictive in vivo pharmacology tools to accelerate preclinical drug development in: Immuno-Oncology (CDX/PDX/Leukemia) Infectious Diseases: HIV, HBV Inflammation: IBD/Colitis, NASH/MASH, lung fibrosis Toxicity/Immuno-toxicity Our state-of-the-art facilities based in France include BSL-2 and -3 labs, advanced flow cytometry, and customized protocols, ensuring flexibility and adaptability to your project’s needs. With over 12 years of expertise, an AAALAC-accredited facility , and affordable pricing, we help save you time and budget while offering robust and predictive data for IND filing.

ArchParc, Le Forum 1 260 Avenue Marie Curie Archamps, 74160 FranceTransCure BioServices is the only CRO specialized in preclinical studies using full human immune system (CD34 engrafted and PBMC engrafted) and humanized liver mouse models. We provide predictive in vivo pharmacology tools to accelerate preclinical drug development in: Immuno-Oncology (CDX/PDX/Leukemia) Infectious Diseases: HIV, HBV Inflammation: IBD/Colitis, NASH/MASH, lung fibrosis Toxicity/Immuno-toxicity Our state-of-the-art facilities based in France include BSL-2 and -3 labs, advanced flow cytometry, and customized protocols, ensuring flexibility and adaptability to your project’s needs. With over 12 years of expertise, an AAALAC-accredited facility , and affordable pricing, we help save you time and budget while offering robust and predictive data for IND filing.

4, rue des Terreaux-du-Temple Geneva, CH-1201 SwitzerlandTriskel Integrated Services provides a strategic complement to contract research organisations (CROs), contract manufacturers (CMOs) or other classical service providers, offering consulting services throughout the product's lifespan – from discovery through to the post-authorisation phase.

Place Cornavin 12 - 1201 Geneva, SwitzerlandUnilabs Pharma Solutions is a network of specialist laboratories providing DMPK, bioanalysis, and biomarker services that support pharmaceutical development from late-stage discovery through clinical trials and post-market studies. With laboratories in York and Sandwich (UK) and Copenhagen (Denmark), we work with pharmaceutical companies, biotech firms, CROs, and healthcare organisations worldwide, delivering tailored, scalable analytical solutions backed by scientific expertise, agile project management, and strong regulatory knowledge. Our Copenhagen laboratory specializes in bioanalytical and molecular biology services, focusing on large molecule bioanalysis and biomarker discovery and validation. Through the development and validation of robust analytical methods, we generate precise, reproducible, and regulatory-ready data for preclinical and clinical programs. Our capabilities include molecular biology, large molecule bioanalysis, and biomarker research, supported by techniques such as qPCR/RT-qPCR, ELISA and MSD immunoassays, enzymatic and fluorescence-based assays, PBMC isolation and cell purification workflows, and coagulation assays. By combining validated workflows, rapid turnaround, and decades of scientific experience, we support everything from early discovery screening to complex late-stage studies, helping accelerate drug development and improve patient outcomes through reliable, high-quality data.

4 Boulevard du Pont-d'Arve, Genève, GE 1205, CH

Bd du Pont-d'Arve 40 Bureau R050 GENEVA 4, CH-1211 Switzerland

1 Rue Michel-Servet Genève, GE, 1206 Switzerland

1 Rue Michel-Servet Genève, GE, 1206 Switzerland

155 Chemin des Boveresses Epalinges, VD, 1066 SwitzerlandOur mission is simple - to contribute to the elimination of immunological disorders, parasitic infections and cancer. Achieving this goal begins with cutting-edge teaching and research programs, together with seminars and international conferences in biology and medicine for students and researchers from all over the world. We also seek to foster collaborations between our research groups and the industry so as to provide new paths to therapies and clinical approaches.

Ecublens, VD, 1015 Switzerland

Ecublens, VD, 1015 Switzerland

9 Rue du Bugnon Lausanne, VD, 1005 Switzerland

Ecublens, VD, 1015 Switzerland

Lausanne, VD, 1015 Switzerland